Kanoko Matsumura

Exacerbation of nontuberculous mycobacterial pulmonary disease in a patient with advanced non-small-cell lung cancer during treatment with PD-1 inhibitor and chemotherapy

Young Hak Kim, Y. Shiina, Y. Funada, 2021, Respiratory medicine case reports.

TAPO in first‐line osimertinib therapy and continuation of osimertinib

M. Tachihara, N. Iwamoto, Kanoko Matsumura, 2022, Thoracic cancer.

Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer

M. Satouchi, S. Yoshimura, Y. Kawa, 2023, Heliyon.